Comparison between drug-eluting stents for the treatment of the diffuse type in-stent restenosis after drug-eluting stents implantation: sirolimus-eluting vs. paclitaxel-eluting stents

Trial Profile

Comparison between drug-eluting stents for the treatment of the diffuse type in-stent restenosis after drug-eluting stents implantation: sirolimus-eluting vs. paclitaxel-eluting stents

Completed
Phase of Trial: Phase IV

Latest Information Update: 07 Aug 2012

At a glance

  • Drugs Sirolimus (Primary) ; Paclitaxel
  • Indications Coronary artery restenosis
  • Focus Therapeutic Use
  • Acronyms DES-ISR
  • Most Recent Events

    • 07 Aug 2012 Actual end date (1 Oct 2011) added as reported by ClinicalTrials.gov.
    • 01 Oct 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 04 Aug 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top